Search | IOVS | ARVO Journals

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles February 2021

Low Luminance Visual Acuity and Low Luminance Deficit in Choroideremia and RPGR -Associated Retinitis Pigmentosa

PDF

Laura J. Wood; Jasleen K. Jolly; Amandeep S. Josan; Thomas M. W. Buckley; Robert E. MacLaren
TAGS: choroideremia, luminance, retinitis pigmentosa, visual acuity
Trans. Vis. Sci. Tech.. 2021; 10(2):28. doi: https://doi.org/10.1167/tvst.10.2.28

ARVO Annual Meeting Abstract June 2020

Assessing Residual Photoreceptor Morphology in Choroideremia

Adam M Dubis; Jasleen Kaur Jolly; Lyndon daCruz; Mariya Moosajee; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):819. doi:

ARVO Annual Meeting Abstract July 2019

Cost-effectiveness of Choroideremia Gene Therapy

Celine-Lea Halioua-Haubold; Jasleen Kaur Jolly; David A Brindley; Rafael Pinedo-Villanueva; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5461. doi:

ARVO Annual Meeting Abstract July 2019

Assessment of low luminance visual acuity as a functional measurement in two distinct types of inherited retinal degeneration.

Laura Wood; Jasleen K Jolly; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1817. doi:

ARVO Annual Meeting Abstract July 2019

Validation of Electronic Visual Acuity Measurement Against Standardised ETDRS Charts In Retinal Disease

Jasleen Kaur Jolly; Kristin Juenemann; Heather Boagey; Joanna Moschandreas; Marie Nadsady; Holly Bridge; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1819. doi:

ARVO Annual Meeting Abstract July 2019

Correlation of distinct fundus autofluorescence features with disruption of the overlying ellipsoid zone in choroideremia

Marta Stevanovic; Jasmina Cehajic Kapetanovic; Jasleen Kaur Jolly; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1856. doi:

ARVO Annual Meeting Abstract July 2018

Beyond the average threshold: Alternatives in the analysis of microperimetry data

Iain Robert Wilson; Jasleen Jolly; Susan Downes; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1698. doi:

ARVO Annual Meeting Abstract July 2018

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)

Celine-Lea Halioua-Haubold; Jasleen Jolly; Rafael Pinedo Villanueva; David Brindley; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3897. doi:

ARVO Annual Meeting Abstract July 2018

A detailed in vivo analysis of the retinal nerve fibre layer (RNFL) in choroideremia

Dun Jack Fu; Kanmin Xue; Jasleen K Jolly; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5509. doi:

ARVO Annual Meeting Abstract July 2018

Retinal degeneration in choroideremia follows an exponential decay function

James William Aylward; Kanmin Xue; Maria In?s Patrício; Jasleen K Jolly; Jonathan Charles Wood; Jonathan Brett; Kirti Jasani; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6060. doi:

ARVO Annual Meeting Abstract July 2018

Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial

Robert E MacLaren; Kanmin Xue; Alun R Barnard; Maria In?s Patrício; Thomas L Edwards; Susan Downes; Andrew Lotery; Graeme Black; Andrew Webster; Jasleen K Jolly; Miguel C Seabra

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1195. doi:

Multidisciplinary Ophthalmic Imaging October 2017

Characterizing the Natural History of Visual Function in Choroideremia Using Microperimetry and Multimodal Retinal Imaging

PDF

Jasleen K. Jolly; Kanmin Xue; Thomas L. Edwards; Markus Groppe; Robert E. MacLaren
TAGS: choroideremia, diagnostic imaging of retina, eye, natural history, vision, visual acuity, cohort studies, fovea centralis, tissue degeneration
Invest. Ophthalmol. Vis. Sci.. 2017; 58(12):5575-5583. doi: https://doi.org/10.1167/iovs.17-22486

ARVO Annual Meeting Abstract June 2017

Quality of Life Measures in Patients with Retinal Degeneration

Anum Butt; Jasleen K Jolly; Clare Couldridge; Kanmin Xue; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3295. doi:

ARVO Annual Meeting Abstract June 2017

Assessment of the relationship between CHM gene expression and rate of disease progression in choroideremia

Maria In�s Patrício; Kanmin Xue; Laurel C Chandler; Alun R Barnard; Jasleen K Jolly; Thomas Edwards; Michelle E. McClements; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4528. doi:

ARVO Annual Meeting Abstract June 2017

Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging

Kanmin Xue; Jasleen K Jolly; Thomas Edwards; Markus Groppe; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2480. doi:

Articles December 2016

A Novel Method for Quantitative Serial Autofluorescence Analysis in Retinitis Pigmentosa Using Image Characteristics

PDF

Jasleen K. Jolly; Siegfried K. Wagner; Jonathan Moules; Florian Gekeler; Andrew R. Webster; Susan M. Downes; Robert E. MacLaren
TAGS: autofluorescence, retinitis pigmentosa, luminance
Trans. Vis. Sci. Tech.. 2016; 5(6):10. doi: https://doi.org/10.1167/tvst.5.6.10

Includes: Supplemental Content

Genetics November 2016

The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype

PDF

Matthew P. Simunovic; Jasleen K. Jolly; Kanmin Xue; Thomas L. Edwards; Markus Groppe; Susan M. Downes; Robert E. MacLaren
TAGS: choroideremia, mutation, phenotype
Invest. Ophthalmol. Vis. Sci.. 2016; 57(14):6033-6039. doi: https://doi.org/10.1167/iovs.16-20230

ARVO Annual Meeting Abstract September 2016

Long term vision results following retinal gene therapy for choroideremia

Robert E MacLaren; Thomas L Edwards; Jasleen Jolly; Alun R Barnard; Kanmin Xue; Susan Downes; Graham E Holder; Graeme C.M. Black; Andrew J Lotery; Andrew Webster; Miguel Seabra

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

RPE degeneration precedes photoreceptor and choroidal loss in choroideremia based on enhanced-depth OCT and fundus autofluorescence correlations

Kanmin Xue; Marta Oldani; Jasleen Jolly; Thomas L Edwards; Robert Maclaren

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Structural and functional recovery following iatrogenic macular detachment for retinal gene therapy

Matthew P Simunovic; Jasleen Jolly; Kanmin Xue; Robert Maclaren

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5150. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Low Luminance Visual Acuity and Low Luminance Deficit in Choroideremia and RPGR -Associated Retinitis Pigmentosa

Assessing Residual Photoreceptor Morphology in Choroideremia

Cost-effectiveness of Choroideremia Gene Therapy

Assessment of low luminance visual acuity as a functional measurement in two distinct types of inherited retinal degeneration.

Validation of Electronic Visual Acuity Measurement Against Standardised ETDRS Charts In Retinal Disease

Correlation of distinct fundus autofluorescence features with disruption of the overlying ellipsoid zone in choroideremia

Beyond the average threshold: Alternatives in the analysis of microperimetry data

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)

A detailed in vivo analysis of the retinal nerve fibre layer (RNFL) in choroideremia

Retinal degeneration in choroideremia follows an exponential decay function

Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial

Characterizing the Natural History of Visual Function in Choroideremia Using Microperimetry and Multimodal Retinal Imaging

Quality of Life Measures in Patients with Retinal Degeneration

Assessment of the relationship between CHM gene expression and rate of disease progression in choroideremia

Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging

A Novel Method for Quantitative Serial Autofluorescence Analysis in Retinitis Pigmentosa Using Image Characteristics

The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype

Long term vision results following retinal gene therapy for choroideremia

RPE degeneration precedes photoreceptor and choroidal loss in choroideremia based on enhanced-depth OCT and fundus autofluorescence correlations

Structural and functional recovery following iatrogenic macular detachment for retinal gene therapy

To View More...

You must be signed into an individual account to use this feature.